Arcellx Q2 net loss $32.1M; cash $307M; CART-ddBCMA shows 100% ORR

Arcellx, Inc.

2022-Q2 EPS reported -$2.24

Net loss $32.1M vs $15.9M YoY; R&D spend $23.4M; G&A $9.2M.
Cash, equivalents & securities $307.0M as of June 30, 2022, funding operations for at least 12 months.
Completed $128.8M follow-on offering (8.05M shares at $16.00).
CART-ddBCMA Phase 1: 100% ORR, 71% CR/sCR in r/r MM; no Grade ≥3 CRS at 100M CAR+ cells.
Appointed Michelle Gilson as CFO and Maryam Abdul-Kareem as General Counsel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.